Ex vivo pretreatment of human vessels with siRNA nanoparticles provides protein silencing in endothelial cells

[1]  J. Pober,et al.  Blocking MHC class II on human endothelium mitigates acute rejection. , 2016, JCI insight.

[2]  W. Saltzman,et al.  Cell penetrating peptide-modified poly(lactic-co-glycolic acid) nanoparticles with enhanced cell internalization. , 2016, Acta biomaterialia.

[3]  Arndt F. Siekmann,et al.  MicroRNA 139-5p coordinates APLNR-CXCR4 crosstalk during vascular maturation , 2016, Nature Communications.

[4]  Mike Holcombe,et al.  Modelling the Transport of Nanoparticles under Blood Flow using an Agent-based Approach , 2015, Scientific Reports.

[5]  W. Mark Saltzman,et al.  A holistic approach to targeting disease with polymeric nanoparticles , 2015, Nature Reviews Drug Discovery.

[6]  Daniel G. Anderson,et al.  In vivo endothelial siRNA delivery using polymeric nanoparticles with low molecular weight. , 2014, Nature nanotechnology.

[7]  Christopher J. Cheng,et al.  Sustained delivery of proangiogenic microRNA‐132 by nanoparticle transfection improves endothelial cell transplantation , 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[8]  I. T. Ten Berge,et al.  Immunosuppressive drugs after solid organ transplantation. , 2013, The Netherlands journal of medicine.

[9]  M L Nicholson,et al.  Renal Transplantation After Ex Vivo Normothermic Perfusion: The First Clinical Study , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[10]  Roberto A. Maldonado,et al.  Rapamycin-treated human endothelial cells preferentially activate allogeneic regulatory T cells. , 2013, The Journal of clinical investigation.

[11]  Hermann Brenner,et al.  Kidney Graft Survival in Europe and the United States: Strikingly Different Long-Term Outcomes , 2013, Transplantation.

[12]  Eleonore Fröhlich,et al.  The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles , 2012, International journal of nanomedicine.

[13]  Y. Omidi,et al.  Cytotoxic impacts of linear and branched polyethylenimine nanostructures in a431 cells. , 2011, BioImpacts : BI.

[14]  W. Saltzman,et al.  Polymer nanoparticles encapsulating siRNA for treatment of HSV-2 genital infection. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[15]  W. Mark Saltzman,et al.  Therapeutic siRNA: Principles, Challenges, and Strategies , 2012, The Yale journal of biology and medicine.

[16]  K. Nguyen,et al.  Biodegradable nanoparticles mimicking platelet binding as a targeted and controlled drug delivery system. , 2012, International journal of pharmaceutics.

[17]  W. Sessa,et al.  Reperfusion Injury Intensifies the Adaptive Human T Cell Alloresponse in a Human-Mouse Chimeric Artery Model , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[18]  Marcelo Cypel,et al.  Normothermic ex vivo lung perfusion in clinical lung transplantation. , 2011, The New England journal of medicine.

[19]  W. Mark Saltzman,et al.  Intravaginal gene silencing using biodegradable polymer nanoparticles densely loaded with small-interfering RNA , 2009, Nature materials.

[20]  Daniel G. Anderson,et al.  Knocking down barriers: advances in siRNA delivery , 2009, Nature Reviews Drug Discovery.

[21]  Daniel Irimia,et al.  Synthetic microvascular networks for quantitative analysis of particle adhesion , 2008, Biomedical microdevices.

[22]  Y. Won,et al.  Polymer-based siRNA delivery: perspectives on the fundamental and phenomenological distinctions from polymer-based DNA delivery. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[23]  S. Crampton,et al.  Isolation of human umbilical vein endothelial cells (HUVEC). , 2007, Journal of visualized experiments : JoVE.

[24]  M Ferrari,et al.  The adhesive strength of non-spherical particles mediated by specific interactions. , 2006, Biomaterials.

[25]  Mateusz Kuzak,et al.  DNA/cationic polymer complex attachment on a human vascular endothelial cell monolayer exposed to a steady laminar flow. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[26]  Shubiao Zhang,et al.  Toxicity of cationic lipids and cationic polymers in gene delivery. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[27]  Megan Sykes,et al.  Organ transplantation—how much of the promise has been realized? , 2005, Nature Medicine.

[28]  L. Sharples,et al.  The cumulative effect of acute rejection on development of cardiac allograft vasculopathy. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[29]  M. Eccles,et al.  Conjugate for efficient delivery of short interfering RNA (siRNA) into mammalian cells , 2004, FEBS letters.

[30]  M. Richards,et al.  Human feeders support prolonged undifferentiated growth of human inner cell masses and embryonic stem cells , 2002, Nature Biotechnology.

[31]  A. Krasinskas,et al.  Non-hematopoietic allograft cells directly activate CD8+ T cells and trigger acute rejection: An alternative mechanism of allorecognition , 2002, Nature Medicine.

[32]  J. Pober,et al.  Interferon-γ elicits arteriosclerosis in the absence of leukocytes , 2000, Nature.

[33]  G. Becker,et al.  Impact of acute rejection therapy on infections and malignancies in renal transplant recipients. , 1999, Transplantation.

[34]  J. Pober,et al.  Blockade of CD2-LFA-3 interactions protects human skin allografts in immunodeficient mouse/human chimeras , 1997, Nature Biotechnology.

[35]  B. Mach,et al.  Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA. , 1994, Science.

[36]  G. Maddern,et al.  Extracorporeal machine perfusion of the pancreas: technical aspects and its clinical implications--a systematic review of experimental models. , 2016, Transplantation reviews.

[37]  J. Pober,et al.  Participation of blood vessel cells in human adaptive immune responses. , 2012, Trends in immunology.

[38]  Zhaozhong Jiang,et al.  Biodegradable poly(amine-co-ester) terpolymers for targeted gene delivery. , 2011, Nature materials.

[39]  George A. Calin,et al.  RNA interference in the clinic: challenges and future directions , 2011, Nature Reviews Cancer.

[40]  Koji Nomura,et al.  Challenges and Future Directions , 2005 .

[41]  J. Pober,et al.  Interferon-gamma elicits arteriosclerosis in the absence of leukocytes. , 2000, Nature.

[42]  M. Wilhelm,et al.  Chronic rejection. , 1998, Transplantation proceedings.